A systems biology approach for the identification of significantly perturbed genes
暂无分享,去创建一个
Sorin Draghici | Michele Donato | Adib Shafi | S. Drăghici | Adib Shafi | M. Donato | Michele Donato
[1] Mario Lauria,et al. Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge , 2013, Bioinform..
[2] Sorin Draghici,et al. Incorporating Gene Significance in the Impact Analysis of Signaling Pathways , 2012, 2012 11th International Conference on Machine Learning and Applications.
[3] Robert Gentleman,et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.
[4] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[5] Christina Backes,et al. An integer linear programming approach for finding deregulated subgraphs in regulatory networks , 2011, Nucleic acids research.
[6] A. Papavassiliou,et al. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk , 2012, International Journal of Colorectal Disease.
[7] Bin Zhao,et al. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal , 2011, Nature Cell Biology.
[8] Martin Ester,et al. Optimally discriminative subnetwork markers predict response to chemotherapy , 2011, Bioinform..
[9] Hui-Young Lee,et al. Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells. , 2011, Biochemical and biophysical research communications.
[10] Hong Chen,et al. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. , 2011, Oncology reports.
[11] M. Sughrue,et al. Cancer and the Complement Cascade , 2010, Molecular Cancer Research.
[12] Eli Upfal,et al. Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.
[13] W. V. van IJcken,et al. Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.
[14] I. Kim,et al. PTEN/pAkt/p53 signaling pathway correlates with the radioresponse of non-small cell lung cancer. , 2010, International journal of molecular medicine.
[15] Z. Qian,et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer , 2010, British Journal of Cancer.
[16] H. Tian,et al. Depletion of PI3K p85α induces cell cycle arrest and apoptosis in colorectal cancer cells , 2009 .
[17] H. Tian,et al. Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells. , 2009, Oncology reports.
[18] Marc Ladanyi,et al. WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis , 2009, Cell.
[19] Wei-peng Zhao,et al. Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cells. , 2009, Oncology reports.
[20] Francesca Molinari,et al. PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. , 2009, Cancer research.
[21] Holger Sültmann,et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. , 2009, Lung cancer.
[22] Zsolt Tulassay,et al. Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature , 2008, Disease markers.
[23] Richard M. Karp,et al. Detecting Disease-Specific Dysregulated Pathways Via Analysis of Clinical Expression Profiles , 2008, RECOMB.
[24] Ying-Xuan Chen,et al. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. , 2008, Neoplasia.
[25] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[26] J. Minna,et al. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1 , 2007, Oncogene.
[27] P. Khatri,et al. A systems biology approach for pathway level analysis. , 2007, Genome research.
[28] Y. Takano,et al. Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. , 2007, Anticancer research.
[29] C. Der,et al. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.
[30] A. Darzi,et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer , 2007, Clinical & Experimental Metastasis.
[31] Serban Nacu,et al. Gene expression network analysis and applications to immunology , 2007, Bioinform..
[32] K. Ho,et al. A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.
[33] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[34] D. Lin,et al. Abnormal β-Catenin and Reduced Axin Expression Are Associated With Poor Differentiation and Progression in Non–Small Cell Lung Cancer , 2006 .
[35] Hyun-Ah Kim,et al. Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. , 2006, Experimental and molecular pathology.
[36] S. Brand,et al. Cell differentiation dependent expressed CCR6 mediates ERK‐1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells , 2006, Journal of cellular biochemistry.
[37] Z. Szallasi,et al. Reliability and reproducibility issues in DNA microarray measurements. , 2006, Trends in genetics : TIG.
[38] Yiling Lu,et al. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.
[39] S. Brand,et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. , 2005, Experimental cell research.
[40] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.
[41] C. Forst,et al. Differential network expression during drug and stress response , 2005, Bioinform..
[42] Sunil Singhal,et al. Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review , 2005, Clinical Cancer Research.
[43] Pankaj Agarwal,et al. Inferring pathways from gene lists using a literature-derived network of biological relationships , 2005, Bioinform..
[44] U. Lindforss,et al. Persistence of K-ras mutations in plasma after colorectal tumor resection. , 2005, Anticancer research.
[45] Gordon K Smyth,et al. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.
[46] V. Keshamouni,et al. Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer , 2004, Oncogene.
[47] K. Fransén,et al. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. , 2003, Carcinogenesis.
[48] Adam J. Smith,et al. The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..
[49] Biao He,et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression , 2003, Oncogene.
[50] Jeffrey S. Morris,et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[51] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[52] A. Kakkar,et al. Platelets and cancer. , 2002, The Lancet. Oncology.
[53] Benno Schwikowski,et al. Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.
[54] J. Tartaglia,et al. Therapeutic vaccines against melanoma and colorectal cancer. , 2001, Vaccine.
[55] K. Sugimachi,et al. Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance , 2000 .
[56] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[57] R. Tibshirani,et al. An Introduction to the Bootstrap , 1995 .
[58] E. Brambilla,et al. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. , 1992, Human pathology.
[59] J. Mattick,et al. Genome research , 1990, Nature.
[60] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.